Colorectal Cancer and Polyglucosamine: state of art

Authors

  • U. Cornelli Adjunct Professor of Pharmacology Loyola University School of Medicine Chicago USA
  • G. Belcaro Professor of Angiology Irwin Labs University of Chieti Italy

Keywords:

Colorectal cancer, Polyglucosamine

Abstract

A brief analysis of the colorectal cancer (CRC) development in the world was conducted, followed by the description of the most known causes of the disease and the possible remedies. A tentative prevention can be suggested using polyglucosamine (PG L112) which mechanistically has some characteristics that can counteract the development of the disease.

Downloads

Download data is not yet available.

Author Biography

U. Cornelli, Adjunct Professor of Pharmacology Loyola University School of Medicine Chicago USA

Umberto Cornelli MD, PhD
Loyola University School of Medicine
Chicago, USA
E-mail: ucornelli@gmail.com

Published

2017-06-01

How to Cite

[1]
U. Cornelli and G. Belcaro 2017. Colorectal Cancer and Polyglucosamine: state of art. Journal of Applied Cosmetology. 35, 1/2 (Jun. 2017), 1/14.

Issue

Vol. 35 No. 1/2 (2017): Journal of Applied Cosmetology

Section

OBSERVATIONAL STUDY
Copyright & Licensing